Journals
Publish with us
Publishing partnerships
About us
Blog
Evidence-Based Complementary and Alternative Medicine
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Evidence-Based Complementary and Alternative Medicine
/
2022
/
Article
/
Tab 1
/
Research Article
Network Pharmacology and Experimental Validation to Reveal Effects and Mechanisms of Icariin Combined with Nobiletin against Chronic Obstructive Pulmonary Diseases
Table 1
Binding energy between components and 7 highest scoring targets (kcal/mol).
Components
CID
Targets
PDB ID
Binding energy
Icariin
5318997
AKT
2UZR
−4.38
Icariin
5318997
EGFR
5Y9T
−5.84
Icariin
5318997
MMP9
1L6J
−5.32
Icariin
5318997
JUN
5T01
−3.25
Icariin
5318997
SRC
2BDF
−2.95
Icariin
5318997
TNF
7KP9
−4.28
Nobiletin
72344
AKT
2UZR
−5.36
Nobiletin
72344
EGFR
5Y9T
−5.85
Nobiletin
72344
MMP9
1L6J
−6.2
Nobiletin
72344
SRC
2BDF
−6.18
Nobiletin
72344
VEGFA
7LL8
−5.84